Switch to:
More From Other Websites
EU regulator accepts Sanofi/Regeneron's Dupixent product for review Dec 08 2016
Sanofi and Regeneron Announce Marketing Authorization Application for Dupixent® (dupilumab)... Dec 08 2016
Regeneron and Sanofi Announce Marketing Authorization Application for Dupixent® (dupilumab)... Dec 08 2016
Trump Talk Moves Market Again — Who Is It This Time? Dec 07 2016
Hedge Funds Are Dumping Regeneron Pharmaceuticals Inc (REGN) Dec 07 2016
The Zacks Analyst Blog Highlights: Booz Allen Hamilton Holding, McDonald's, Regions Financial and... Dec 07 2016
Play the Trump Factor with these 4 Large-Cap Stocks Dec 06 2016
Jim Cramer's 'Mad Money' Recap: How to Handle Your Finances at Any Age Dec 02 2016
Amgen, Regeneron 2017 LDL-Busters Could Boost This Small-Cap Biotech Dec 02 2016
The Numbers Behind a Pharma CEO Shouting Match Dec 02 2016
Pharma CEOs got into a heated debate over why people hate the industry Dec 01 2016
Pharma execs weigh in on possible changes under Trump Dec 01 2016
Pharma execs weigh in on possible changes under Trump Dec 01 2016
Biotechs Aerie, Medicines Co., Tesaro Could Rocket, Or Be Bought: RBC Dec 01 2016
What Regeneron's CEO Thinks About Drug Pricing Under Trump Dec 01 2016
5 Top Performing Biotechnology Stocks of November Dec 01 2016
Drugs Delayed By Regeneron, Sanofi Plant (REGN, SNY) Dec 01 2016
Regeneron CEO on drug pricing Dec 01 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK